Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the ProShares Ultra Nasdaq Biotechnology ETF (BIB), we found that the implied analyst target price for the ETF based upon its underlying holdings is $57.01 per unit.
START SLIDESHOW:
10 ETFs With Most Upside To Analyst Targets »

Name | Symbol | Recent Price | Avg. Analyst 12-Mo. Target | % Upside to Target |
---|---|---|---|---|
ProShares Ultra Nasdaq Biotechnology ETF | BIB | $47.26 | $57.01 | 20.62% |
Arrowhead Pharmaceuticals Inc | ARWR | $4.18 | $10.83 | 159.16% |
Foamix Pharmaceuticals Ltd. | FOMX | $8.74 | $22.50 | 157.44% |
Omeros Corp | OMER | $12.65 | $31.60 | 149.80% |
The average analyst target price data upon which this article was based, is courtesy of data provided by Zacks Investment Research via Quandl.com.
Get the latest Zacks research report on ARWR — FREE
Get the latest Zacks research report on FOMX — FREE
Get the latest Zacks research report on OMER — FREE